Literature DB >> 11373321

Quantitative comparison of growth-associated protein-43 and substance P in ulcerative colitis.

P Vento1, T Kiviluoto, U Keränen, H J Järvinen, E Kivilaakso, S Soinila.   

Abstract

The aim of this study was to compare immunoreactivities for substance P with other enteric neuropeptides and GAP-43, a general marker for enteric nerves, in normal human colon and in different stages of ulcerative colitis. Tissue samples from normal colon and regions of ulcerative colitis colon were obtained at surgery and immunostained for substance P, vasoactive intestinal polypeptide (VIP), somatostatin, calcitonin gene-related peptide (CGRP), enkephalin, galanin, GAP-43, and neuron-specific enolase (NSE). Visual examination and semiquantitative analysis revealed a clear increase in the immunoreactivity for substance P in ulcerative colitis, whereas no differences were observed in the distribution of the other peptides. Therefore, quantitative analysis was performed only for substance P immunoreactivity in the lamina propria, circular muscle layer, and myenteric ganglia. In the lamina propria, the score of total intensity of substance P immunoreactivity was 0.55 +/- 0.15 (mean +/- SEM) in normal colon, 1.30 +/- 0.35 (p = 0.087) in least affected colon, and 2.22 +/- 0.28 (p < 0.001) in moderately affected colon, whereas no significant differences were observed in immunoreactivities for GAP-43. Similar results were obtained for the mean substance P- or GAP-43-immunoreactive area. In the circular muscle layer, the number, density, total intensity, and perimeter of substance P- and GAP-43-immunoreactive fibers were essentially similar in normal colon, and in mild or moderately affected colon. We conclude that ulcerative colitis does not change the density of gut innervation as a whole. However, the density of substance P-containing nerves is specifically increased, probably due to increased peptide synthesis leading to better visibility of the fibers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11373321     DOI: 10.1177/002215540104900608

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  6 in total

1.  Changes in chemical coding of myenteric neurones in ulcerative colitis.

Authors:  M Neunlist; P Aubert; C Toquet; T Oreshkova; J Barouk; P A Lehur; M Schemann; J P Galmiche
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

2.  Ketamine-induced ventricular structural, sympathetic and electrophysiological remodelling: pathological consequences and protective effects of metoprolol.

Authors:  Y Li; J Shi; B F Yang; L Liu; C L Han; W M Li; D L Dong; Z W Pan; G Z Liu; J Q Geng; L Sheng; X Y Tan; D H Sun; Z H Gong; Y T Gong
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  Association of genetic variants in tachykinins pathway genes with colorectal cancer risk.

Authors:  Yunxian Yu; Yifeng Pan; Mingjuan Jin; Mingwu Zhang; Shanchun Zhang; Qilong Li; Xia Jiang; Hui Liu; Jing Guo; He Liu; Kun Chen
Journal:  Int J Colorectal Dis       Date:  2012-06-26       Impact factor: 2.571

4.  Morphology of enkephalin-immunoreactive myenteric neurons in the human gut.

Authors:  A Brehmer; T M Lindig; F Schrödl; W Neuhuber; D Ditterich; M Rexer; H Rupprecht
Journal:  Histochem Cell Biol       Date:  2005-03-18       Impact factor: 4.304

5.  Contribution of bone marrow-derived cells to the pro-inflammatory effects of protease-activated receptor-2 in colitis.

Authors:  Eric Hyun; Patricia Andrade-Gordon; Martin Steinhoff; Paul L Beck; Nathalie Vergnolle
Journal:  Inflamm Res       Date:  2010-03-26       Impact factor: 4.575

6.  Profound loss of neprilysin accompanied by decreased levels of neuropeptides and increased CRP in ulcerative colitis.

Authors:  Zeynep Gök Sargın; Nuray Erin; Gokhan Tazegul; Gülsüm Özlem Elpek; Bülent Yıldırım
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.